CDER New September 17, 2015

What's New on the FDA Drugs Site

September 16, 2015

• Drugs@FDA Data Files (updated)
• Manual of Policies and Procedures (MAPP) 7610.7 CDER Data Standards Program (PDF - 188 KB)
• FDA Drug Safety Podcast: FDA revises label of diabetes drug canagliflozin (Invokana, Invokamet) to include updates on bone fracture risk and new information on decreased bone mineral density